Revenue Growth Drivers

High TTM ROIC of 48.0% suggests reinvested capital can compound efficiently, but peer-relative growth evidence is limited by missing multi-year revenue history.

Low R&D intensity at 0.8% of revenue implies a lean cost base, yet it also signals less internal innovation capacity than more research-heavy peers.

Negative net debt to EBITDA indicates balance-sheet flexibility for expansion, although leverage capacity alone does not guarantee faster revenue compounding versus peers.

Absent 5-year revenue CAGR data prevents confirmation of durable historical scaling, so the score relies more on capital efficiency than proven top-line momentum.

Market Tailwinds

No post-August 2025 market evidence was provided, so long-term demand tailwinds cannot be verified and remain weaker than for peers with disclosed expansion catalysts.

The company’s valuation multiples imply investors expect ongoing growth, but market pricing is not evidence of durable revenue expansion capacity.

Missing segmentation concentration data limits assessment of whether the business can scale through diversified end-markets better than peers.

Without filing-based disclosure of addressable-market penetration, tailwind strength remains moderate rather than structurally exceptional.

Scalability Expansion

Very high ROIC supports scalable reinvestment economics, but the lack of disclosed revenue CAGR makes peer comparison on compounding durability incomplete.

Capex-to-revenue at zero suggests an asset-light model, which can scale faster than capital-intensive peers if demand growth is sustained.

Cash conversion cycle of 174.7 days indicates working-capital drag, which can slow expansion relative to peers with faster cash recycling.

Negative net debt provides funding flexibility for growth, yet the absence of evidence on repeatable expansion channels caps the scalability score.

Constraints Limitations

A long cash conversion cycle ties up capital and can constrain reinvestment speed, especially versus peers with shorter operating cycles.

Missing 5-year revenue, EPS, and FCF CAGR data limits confidence in durable compounding, reducing visibility versus better-disclosed peers.

Very low R&D spend may limit product or platform expansion if the business depends on innovation to sustain growth against peers.

No segmentation or concentration metrics were provided, so potential customer or end-market saturation risks cannot be ruled out.

Overall Score

ZTG shows solid reinvestment efficiency and balance-sheet flexibility, but missing multi-year growth evidence and working-capital drag keep long-term scalability below stronger peers.

Score Driver: High ROIC